HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murray, S. P. Articles by Oglevie, S. B. Search for Related Content PubMed PubMed Citation Articles by Murray, S. P. Articles by Oglevie, S. B. Social Bookmarking                      What's this? Hotlight (NEW!) What's Hotlight?

Early Rethrombosis of Clotted Hemodialysis Grafts

Graft Salvage Achieved with an Aggressive Approach

¹ Department of Radiology, University of California—San Diego, 200 W. Arbor Dr., San Diego, CA 92103.
² Present address: Department of Radiology, Kaweah Delta Hospital, 400 W. Mineral King, Visalia, CA 93291-6263.

OBJECTIVE. The purpose of this study was to assess the efficacy of repeated pulsedspray pharmacomechanical thrombolysis for salvage of early rethrombosis of hemodialysis grafts and to identify factors that predict successful outcome.

MATERIALS AND METHODS. Thirty-four patients with initial successful thrombolysis were referred for repeated thrombolysis because of early rethrombosis. Repeated thrombolysis occurred within 1 month of initial thrombolysis. Technical success and patency rates were calculated. Causes of graft thrombosis and procedural modifications were analyzed.

RESULTS. The 39 rethrombosed grafts were successfully treated using pharmacomechanical thrombolysis, and patients underwent subsequent hemodialysis. The underlying flow-limiting stenoses were treated with balloon angioplasty using a larger balloon (41%), a same-size angioplasty balloon (18%), stent placement (15%), or increased anticoagulation (5%). A new stenosis location was discovered in 18%. Mean primary patency was 80.9 days (2.6 months) and secondary patency was 235.4 days (7.8 months). With life table analysis, 1-, 3-, 6-, and 12-month primary patency rates were 72%, 31%, 23%, and 15%, and secondary patency rates were 77%, 62%, 51%, and 31%, respectively. Graft patency rates in our study were compared with our institutional historic graft patency rates, with no significant difference noted (p = 0.76). No major procedural complications occurred.

CONCLUSION. Adequate technical success and patency rates for pharmacomechanical thrombolysis occur even for hemodialysis grafts that rethrombose within 1 month. After thrombolysis, aggressive search for and treatment of additional stenoses are warranted.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. V. Lombardi, M. J. Dougherty, N. Veitia, J. Somal, and K. D. Calligaro A Comparison of Patch Angioplasty and Stenting for Axillary Venous Stenoses of Thrombosed Hemodialysis Grafts Vascular and Endovascular Surgery, May 1, 2002; 36(3): 223 - 229. [Abstract] [PDF]